Zhitong Finance App News, Health 160 (02656) issued an announcement. The Group has recently completed the delivery of an integrated solution (this order) with a total amount of RMB 12.2 million to a major health enterprise (customer) focusing on the development of smart wearable health devices through domestic subsidiaries, and has obtained acceptance documents issued by the customer. As far as the Board knows, knows and believes, the customer and its ultimate beneficial owner are third parties independent of the Company and its related parties.
Under this order, the Group provides the customer with an integrated solution (“Solution”) including an intelligent health monitoring system, computing power infrastructure and integrated debugging services. After delivery, the solution will support real-time access, cleaning and storage of high-frequency sign data from customers' massive terminal devices, and rely on computing power to achieve core functions such as AI health inference, risk warning, and user health file management.
The Group has long been deeply involved in the Internet medical field, has accumulated rich service experience in the healthcare industry, and has a large number of intellectual property rights such as invention patents and software copyrights. Based on its platform, the Group has created 160 AI hospitals through deep integration of AI application upgrades and innovatively launched the “160AI Hospital” operation cooperation business model, and continues to promote the implementation of AI agents in medical scenarios. At present, the Group has formed an integrated model of “platform+AI agent+operation”, fully introducing AI agents into the internal operation system and applying them to product R&D, content output and customer service, significantly improving the Group's overall operational efficiency and professional service capabilities.
In order to seize market opportunities for the integrated development of AI technology and healthcare, the Group is trying to expand on the existing business basis, integrate its own intelligent health monitoring system and computing power infrastructure to form an integrated solution of “medical AI agent+hardware+integrated debugging service” to provide customers in the healthcare sector with overall delivery of AI medical products and computing power infrastructure, further enriching the Group's product matrix.
The board of directors believes that the smooth delivery and acceptance of this solution is an important exploration and key breakthrough point for the Group's new business path in the field of healthcare and AI computing power integration. The Group notes that with the continuous deepening and improvement of the application of AI technology in the healthcare industry, the demand for integrated delivery of “AI application+computing power infrastructure” from downstream customers is gradually being released. In particular, in scenarios such as smart wearable health monitoring and chronic disease management, the collaborative deployment of AI software platforms and computing power infrastructure has become a key part of achieving a closed loop of business for healthcare enterprise customers. By combining its own software capabilities with computing power infrastructure, the Group can provide more valuable digital healthcare solutions to downstream customers in need, further broaden business boundaries and service depth, move towards achieving the strategic goal of moving from a “comprehensive digital healthcare service platform” to a “medical AI intelligent ecosystem infrastructure and operation service provider”, and enrich the Group's revenue sources.